Actively Recruiting

Phase Not Applicable
Age: 25Years - 59Years
All Genders
NCT05997212

Effect of Repetitive TMS on Executive Function in Alcohol Use Disorder

Led by Universidad Nacional Autonoma de Mexico · Updated on 2025-02-10

44

Participants Needed

1

Research Sites

137 weeks

Total Duration

On this page

Sponsors

U

Universidad Nacional Autonoma de Mexico

Lead Sponsor

N

National Council of Science and Technology, Mexico

Collaborating Sponsor

AI-Summary

What this Trial Is About

Alcohol Use Disorder (AUD) is a major public health problem that affects the physical, social, family, and mental integrity of the sufferer. Behavioral self-regulation is compromised in AUD, and a benefit has been reported with the application of repetitive transcranial magnetic stimulation and emotional self-regulation. The aim of this study is to investigate the efficacy of high-frequency rTMS to improve executive functions in patients in abstinence from AUD.

CONDITIONS

Official Title

Effect of Repetitive TMS on Executive Function in Alcohol Use Disorder

Who Can Participate

Age: 25Years - 59Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women aged 25 to 59 years
  • Reading level of at least 6th grade of primary school (equivalent to fifth grade of elementary school)
  • Alcohol users with an AUDIT score of 20 or higher
  • Abstinent from alcohol consumption for 8 weeks to 5 years, with CIWA-Ar scale scores of 9 or less
  • No disabling neuropsychiatric conditions such as schizophrenia
  • No substance use disorders except for alcohol and nicotine
  • Breath alcohol concentration (BrAC) of 0.00 mg/dl during assessments
  • No traces of alcohol detected using urine test strips
  • No contraindications for TMS therapy
Not Eligible

You will not qualify if you...

  • Symptoms of severe agitation or inability to cooperate in the study
  • History of epilepsy
  • Sudden onset of stroke or neurological problems like hemiparesis, sensory loss, visual field deficits, or lack of coordination
  • Seizures or gait disturbances
  • History of severe psychiatric disorders
  • Alterations in a conventional electroencephalogram
  • Presence of pacemakers or intracranial metallic objects
  • Withdrawal from the study upon participant's request
  • Adverse incidents worsening health limiting continuation of rTMS treatment
  • Exacerbation of cognitive or behavioral symptoms during treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Unidad de Resonancia Magnética

Querétaro City, Querétaro, Mexico, 76230

Actively Recruiting

Loading map...

Research Team

A

Alejandra Lopez Castro, MD, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here